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Abstract: Background: Research indicates potential cardiometabolic benefits of energy consumption
earlier in the day. This study examined the association between fasting duration, timing of first
and last meals, and cardiometabolic endpoints using data from the National Health and Nutrition
Examination Survey (NHANES). Methods: Cross-sectional data from NHANES (2005–2016) were
utilized. Diet was obtained from one to two 24-h dietary recalls to characterize nighttime fasting
duration and timing of first and last meal. Blood samples were obtained for characterization of
C-reactive protein (CRP); glycosylated hemoglobin (HbA1c %); insulin; glucose; and high-density
lipoprotein (HDL), low-density lipoprotein (LDL), and total cholesterol. Survey design procedures for
adjusted linear and logistic regression were performed. Results: Every one-hour increase in nighttime
fasting duration was associated with a significantly higher insulin and CRP, and lower HDL. Every
one-hour increase in timing of the last meal of the day was statistically significantly associated with
higher HbA1c and lower LDL. Every one-hour increase in first mealtime was associated with higher
CRP (β = 0.044, p = 0.0106), insulin (β = 0.429, p < 0.01), and glucose (β = 0.662, p < 0.01), and lower
HDL (β = −0.377, p < 0.01). Conclusion: In this large public health dataset, evidence for the beneficial
effect of starting energy consumption earlier in the day on cardiometabolic endpoints was observed.
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1. Introduction
Diet is one of the strongest modifiers of cardiometabolic markers [1–4]. However,
for much of the American adult population, dietary modification has been a challenge
and has not led to significant public health improvements [5,6]. This is evidenced by the
obesity and diabetes epidemics in the United States [7,8]. Furthermore, as a population,
Americans have been shown to not follow dietary recommendations [9]. Attempts to
lessen the obesity burden have mostly focused on reducing overall energy intake [10–12].
While modest caloric restriction (~500 kilocalories (kcals)/day reduction) has led to weight
loss and improvements in other cardiometabolic endpoints [13–15], participants often
experience increases in hunger [16–18], making it difficult to sustain this type of behavior.
Furthermore, most will regain their weight-loss over a period of years [5,6].
Intermittent fasting (IF) involves varying degrees of voluntary restriction of energy
for some period of time [19], and has been associated with weight loss [20–22]. IF covers
protocols such as complete day or modified 5:2 regimens, time-restricted feeding (TRF) in
which timing of food consumption is restricted to a time window (e.g., 8 h) during the day,
and fasting due to religious beliefs such as Ramadan [19].
Of growing interest are protocols involving early TRF (eTRF). However, there are no
precise definitions of eTRF; generally, consumption typically ends by 4 or 5 PM. Research
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shows the profound effect that IF can have on a range of outcomes including weight loss
and metabolic disease [23–25]. Biologically, irrespective of weight loss, IF can elicit adaptive
cellular responses within and between organs in a way that reduces inflammation, and
improves glucose regulation, and resistance against oxidative and metabolic stress [23].
Recently, Pellegrini and colleagues conducted a meta-analysis of 11 clinical trials or
pragmatic designs examining the impact of either TRF or eTRF on weight loss. Compared to ad libitum eating control groups, those undergoing TRF protocols (weighted
mean difference = −1.07 kg, 95% confidence interval [95%CI] = −1.74 to −0.40) lost more
weight [26]. Overall, reductions in the mean difference of fasting glucose between TRF and
ad libitum groups were found (weighted mean difference = −1.71 mg/dL, 95%CI = −3.20
to −0.21). However, no such finding for insulin was found [26]. In pragmatic trials of
Ramadan, fasting plasma glucose either showed a null change or an increase [26–28]. This
may be related to circadian rhythms with decreased insulin secretion and peripheral and
hepatic insulin resistance towards the evening hours [29,30].
Results for the effect of TRF on measures of inflammation are mixed at best. More
observational or pragmatic designs tend to show an improvement in inflammatory profiles
with TRF [31,32]. However, in more controlled studies, such as randomized controlled
trials (RCTs), associations between TRF and inflammation tend to be null [33,34]. Lastly,
the meta-analysis by Pellegrini and colleagues found null associations between TRF and
cholesterol (total, high-density lipoprotein [HDL], low density lipoprotein [LDL]), and
triglycerides [26], although other types of fasting, such as alternate day fasting, have shown
improvements in levels of these markers, as indicated by Stekovic and colleagues, as an
example [35].
A recent systematic review of IF approaches on a range of outcomes concluded
that there is a large degree of heterogeneity between studies and findings [36]. One
methodological flaw is that TRF naturally leads to moderate calorie restriction. This makes
parsing out the effect of TRF from calorie restriction difficult. [37,38]. For example, a review
found that 9 of 11 studies comparing some form of IF to continuous calorie restriction
found similar effects on weight reduction. Most of those 9 studies also showed a decrease
in energy intake among the IF groups [39]. Interestingly, one study compared alternate-day
fasting with energy restriction to alternate-day fasting without energy restriction over three
weeks. The fasting group with energy restriction had decreased total body mass and fat
mass, but such reductions among the fasting group without energy restriction was not
observed [40]. Regardless, much of the evidence related to TRF and cardiometabolic health
have been in the form of highly controlled RCTs of short duration or pragmatic designs
using religious fasting [36,37].
Given that prior TRF work may be biased by inherent calorie restriction, it was broadly
theorized that usage of a population-based study, such as the National Health and Nutrition
Examination Survey (NHANES), would be able to assess the association between fasting
and cardiometabolic markers without overlapping calorie restriction as most people are
not actively dieting or specifically cutting calories [37,38]. Additionally, a larger population,
especially a population such as NHANES, leads to greater power to detect associations.
NHANES also is representative of the general U.S. population, whereas smaller RCT
populations usually are not.
Therefore, this study examined the impact of fasting on cardiometabolic markers using
data from the NHANES. It was hypothesized that those with shorter nighttime fasting
will have higher values of CRP, glycosylated hemoglobin (HbA1c %), insulin, glucose,
LDL cholesterol, and total cholesterol; and lower HDL cholesterol compared to those with
longer fasting durations. The impact of the timing of the last daily meal and first daily
meal with the outcomes was explored.
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2. Materials and Methods
2.1. Study Population
NHANES regularly collects data on American adults and children using a complex,
multistage, probability sampling design making it a representative U.S.-based sample.
These cross-sectional data are collected in 2-year cycles. For this analysis, NHANES data
were restricted to those at least 18 years of age. Initially, participants are asked to complete
a battery of questionnaires obtaining information on demographics, medical histories,
socioeconomics, and behavioral and lifestyle habits. Then, participants were invited to
attend a mobile examination clinic (MEC) where clinic measurements are performed.
Additionally, biological samples are obtained. Full information on NHANES and the
types of data available can be found elsewhere [41]. Informed consent was provided by
participants and the National Center for Health Statistics Research and Ethics Review
Board continually approves NHANES.
2.2. Outcome Assessment
While attending the MEC and in a seated position, blood was drawn by a trained
phlebotomist. CRP was only available for three 2-year cycles and had an unweighted
sample size of 15,939. Glucose, insulin and LDL were available for all six of the 2-year
cycles but only for a subsample of the population (n = 15,068 for glucose, 14,757 for insulin,
and 14,539 for LDL). The remaining outcomes (total cholesterol, HDL, HbA1c %) were
available for all six of the 2-year cycles for most of the adult (i.e., ≥18 years) participants
(n = 30,793 for total cholesterol; 30,793 for HDL; and 31,069 for HbA1c %). Numerous
protocols underwent quality control procedures including performing blind split samples
collected on “dry run” sessions within the MEC. Each lab involved in analyzing the
blood samples underwent rigorous QA/QC procedures which included a random 2%
retesting [41]. All outcome measures were analyzed continuously using linear regression
(see statistical analysis section). Additionally, each has a standardized cut-point used in
clinical practice. The cut-points for HDL, LDL, and cholesterol were 50, 130, and 210 mg/dL,
respectively [42,43]. The cut-point for CRP was set to 3 mg/L [44]. We excluded participants
with CRP more than 15 md/dL (n = 863) since it may be an indicator of acute infection.
For insulin, HbA1c, and fasting glucose, we used 10.57 µU/mL, 6.5%, and 7.1 mmol/L
as cut-points, respectively [45–47]. Values higher than the cut-points were considered the
outcome of interest, except for HDL in which lower values were considered the outcome of
interest in logistic regression models (see statistical analysis section).
2.3. Exposure Assessment
NHANES uses 24-h dietary recall interviews (24HRs). Data from both days of 24HR
reporting were utilized in this work. NHANES processed the dietary data to obtain micro
and macronutrients by using the USDA’s Food and Nutrient Database for Dietary Studies.
To calculate fasting durations, average start and end times for consumption across the two
days were utilized. If a participant only had the first day of 24HR reporting, then only
the first day was used. Participants were asked to report every food they consumed from
midnight to 11:59 p.m. For calculation of nighttime fasting duration, it is better to start with
first consumption after waking and end with last consumption prior to sleep (although
late night eating during the sleep period still needs to be considered). The NHANES
diet reporting protocol required assumptions to be made for fasting duration derivation.
The designation of “breakfast” was assumed to be the first meal of the day after waking.
Therefore, any consumption of food or drinks prior to breakfast (i.e., between midnight and
breakfast) was assumed to be the last consumption prior to bedtime for those going to sleep
after midnight. As an illustration, suppose participant X consumed food at 1:00 a.m., then
reported breakfast at 8:00 a.m., and ended their day of reporting with food consumption
at 10:00 p.m. According to NHANES coding practices, the 1:00 a.m. food consumption
was the first meal consumed during the day. However, it was most likely the last meal
consumed prior to going to bed (on the previous day). Therefore, this participant would
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have a fasting time from 1:00 a.m. to 8:00 a.m., not 10:00 p.m. to 8:00 a.m. In referring to just
the 2015–2016 cycle, only 18 participants had a dietary pattern where such an assumption
had to be made. To calculate fasting durations, all food consumption times were converted
to hours throughout a 24-h period. For example, food consumed at 8:30 a.m. was valued at
8.5 h. Foods consumed between midnight and breakfast were recoded to be later than 24 h
(i.e., 1:00 a.m. was converted to 25 h). The algorithm to calculate fasting durations was:
24 − last consumption + first consumption. A participant that had breakfast at 8:00 a.m.
and had their last consumption at 10:00 p.m. (i.e., 22 h) would have a fasting duration of
24 − 22 + 8 = 10 h of fasting. Fasting durations were analyzed continuously as well as
in quartiles.
2.4. Statistical Analyses
All analyses accounted for the clustered sampling design and the examination survey
weights as required for appropriate analysis of these data. Given the outcomes were
available for a different number of 2-year cycles, various sampling weights were used.
We used 6-year weights for CRP and 12-year weights for HbA1c %, and total and HDL
cholesterol. We used 12-year fasting blood sample weights for fasting glucose, insulin, and
LDL cholesterol. Population characteristics and crude outcome data were described by
quartiles of fasting durations. For categorical measures, only weighted percentages were
provided as raw sample sizes of weighted data are not very meaningful. For continuous
measures, weighted means and standard deviations were presented.
We performed multiple linear regression models with potential confounders that
may bias the relationship between fasting duration and the cardiometabolic markers. a
priori selected covariates included age (per 10 years), sex (male or female), race/ethnicity
(Mexican American, non-Hispanic white, non-Hispanic black, others), alcohol use (drinker,
non-drinker), marital status (married/living with partner, window or divorced or separated, single), smoking status (current, former, never), sleep duration (<7 h, ≥7 h), use of
cholesterol medication (yes or no), number of days measuring the fasting duration (one or
two), and BMI (under or normal, overweight, obese), Energy-density Dietary Inflammatory
Index (E-DII® , quartiles), and energy intake (quartiles). The E-DII quantifies the degree
of anti- or pro-inflammatory potential [48] and served as a measure of diet quality for
adjustment purposes. Results of regression analyses were presented as β-values (standard
errors [SE]) and p values. We also explored quartiles of fasting durations with the primary
comparison of interest occurring between quartiles 1 and 4. This approach allowed for
quantification of least square means per fasting quartile which may increase interpretability
and use in clinic settings. The timing of the last meal of the day and the timing of the first
meal of the day were analyzed in the same exact manner as described above for fasting
times. The quartile ranges for last mealtime and first mealtime can be found in Table 4.
Upon reviewing results using first mealtime as the independent variable, it was decided to
examine the interaction between first mealtime and fasting duration in attempts to explain
the findings observed for fasting duration analyses. The quartile forms of first mealtime
and fasting duration were used. Specifically, results using the first and fourth quartiles are
presented as these represent the earliest and latest times for first mealtime and the shortest
and longest fasting durations.
Serum biomarkers were then categorized using the clinical cut-points defined above.
For these categorical outcomes, we conducted logistic regression to investigate the associations between the fasting duration and abnormality of serum biomarkers. All logistic
models used the same adjustments as the linear models.
We performed several sensitivity analyses to test the robustness of our main results.
First, we conducted analyses by excluding potential shift workers (n = 803). These were
determined based on timing of main meals (i.e., breakfast, lunch, and dinner). For example,
if a participant reported lunch at midnight and dinner at 4:00 a.m., it was assumed that such
an individual was a shift worker. Second, we tested whether weekends or weekdays would
affect our main results by excluding participants who reported their diets for weekend
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days (n = 451). Third, we repeated our analyses by excluding the extreme values of fasting
duration, such as ≥23 or ≤2 h (n = 76). We set the two-sided p < 0.05 as statistically
significant. All analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary,
NC, USA).
3. Results
Compared to those with the longest nighttime fasting duration, those with the shortest
nighttime fasting duration were more likely to be currently married (55% vs. 67%), be
non-Hispanic white (57% vs. 74%), consume alcohol (23% vs. 32%), be males (44% vs. 55%),
and be older (mean age 43.9 vs. 48.3 years). All p-values for these differences were <0.01
(Table 1).
Table 1. Characteristics of participants according to the quartiles of fasting time in NHANES (2005–2016).
Quartiles of Fasting Duration

Characteristics
Median of fasting duration (h)
Range of fasting duration (h)
Smoking status (%)
Never
Former
Current
Marital status (%)
Married/living with partner
Widow, divorced, separated
Single
Race (%)
Mexican American
Non-Hispanic white
Non-Hispanic black
Other
Alcohol drinker (Yes, %)
Cholesterol medication (Yes, %)
Gender (Female, %)
Age (years), mean (SE)
BMI (kg/m2 ), mean (SE)
Sleep duration (h), mean (SE)
Energy intake (kcal), mean (SE)
DII, mean (SE)

Quartile 1

Quartile 2

Quartile 3

Quartile 4

9.75
<10.75

11.5
10.75–12.16

12.88
12.17–13.75

15
≥13.75

48
27
25

55
26
19

60
24
16

58
20
22

67
19
14

68
18
15

65
17
18

55
19
26

6
74
9
11
32
17
44
48.3 (0.30)
28.5 (0.12)
6.8 (0.02)
2433 (19)
0.41 (0.04)

8
72
9
12
30
17
52
47.7 (0.28)
28.8 (0.12)
7.1 (0.02)
2243 (14)
0.28 (0.04)

9
67
11
13
26
18
57
47.8 (0.39)
28.9 (0.11)
7.2 (0.02)
2062 (13)
0.34 (0.04)

11
57
17
14
23
14
55
43.9 (0.38)
29.4 (0.13)
7.2 (0.02)
1897 (17)
0.73 (0.03)

Abbreviations: DII = Dietary Inflammation Index; MET = metabolic equivalents; SE = standard error; BMI = body mass index;
MVPA = moderate-to-vigorous physical activity. Percentages, means, and standard errors (standard error) were estimated using 12years US population weights. Categorical variables were presented as percentage and continuous variables were presented as mean
(standard error). Column percentages may not equal 100% due to rounding. p-values were calculated from Chi-Square test for categorical
variables and ANOVA for continuous variables. All p-values comparing the characteristics across fasting quartiles were ≤0.01.

The primary analyses utilized fasting durations as a continuous metric. For every
one-hour increase in nighttime fasting duration, average insulin and CRP increased by
0.287 uU/mL (standard error [SE] = 0.057, p < 0.01) and 0.03 mg/L (SE = 0.012, p = 0.02),
respectively. Additionally, for every-hour increase in fasting duration, lower HDL of 0.101
mg/dL (SE = 0.046, p = 0.03) was observed. When using fasting durations as quartiles
with the primary comparison between quartiles 4 and 1, those in quartile 4 (i.e., longest
fasting duration) compared to quartile 1, had statistically significantly greater CRP (3.01
vs. 2.69 mg/dL, p < 0.001) and insulin (14.2 vs. 12.2 mg/dL, p < 0.001), and lower HDL
cholesterol (53.6 vs. 54.3 mg/dL, p = 0.03, Table 2). These findings were opposite compared
to the hypothesized direction.
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Table 2. Associations (least square means and standard errors) between fasting duration and cardiovascular biomarkers in
NHANES (2005–2016).
Biomarker
CRP, mg/dL
Hb1Ac, %
Insulin, uU/mL
Glucose, mg/dL
HDL, mg/dL
LDL, mg/dL
Cholesterol, mg/dL

Quartiles of Fasting Duration
Quartile 1

Quartile 2

Quartile 3

Quartile 4

Per 1 h
β ± SE

Cont.
p-Value

2.69 (0.08)
5.85 (0.02)
12.2 (0.50)
111.0 (0.90)
54.3 (0.28)
106.1 (1.06)
186.9 (0.77)

2.89 (0.09) *
5.86 (0.02)
13.0 (0.39) *
110.9 (0.73)
53.8 (0.31)
106.0 (1.01)
187.2 (0.87)

2.94 (0.09) *
5.89 (0.02)
13.5 (0.42) *
111.9 (0.75)
53.7 (0.29) *
107.1 (1.19)
188.9 (0.80)

3.01 (0.07) *
5.85 (0.02)
14.2 (0.38) *
112.6 (0.91)
53.6 (0.31) *
106.8 (1.06)
188.2 (0.74)

0.030 (0.013)
−0.003 (0.003)
0.287 (0.057)
0.191 (0.147)
−0.103 (0.046)
0.287 (0.158)
0.243 (0.130)

0.02
0.28
<0.01
0.20
0.03
0.07
0.06

Abbreviations: CRP = C-reactive protein; HDL = high-density lipoproteins; LDL = low-density lipoproteins; SE = standard error;
HbA1c = glycosylated hemoglobin. Models adjusted for age (per 10 years), race, gender, marital status, alcohol use, body mass index,
smoking status, sleep duration, cholesterol medicine, days for dietary reports, energy intake, and the Dietary Inflammatory Index. Quartile
ranges: Quartile 1: <10.75, Quartile 2: 10.75–12.16, Quartile 3: 12.17–13.74, Quartile 4: ≥10.75 * Represents means that were statistically
significantly (p < 0.05) different compared to quartile 1.

Next, logistic regression was performed to examine odds of meeting clinical thresholds
for each of the outcomes. Every one-hour increase in fasting duration was associated with
a 7% (95%CI = 1.05–1.10) increase in odds of abnormal insulin and a 1% (95%CI = 1.00–1.03)
increase in odds for abnormal HDL cholesterol. When comparing the highest quartile of
fasting duration to the lower, a statistically significantly elevated odds for values beyond
clinical thresholds was observed for CRP, insulin, and HDL cholesterol (Table 3). Again,
these were in the opposite direction than hypothesized.
Table 3. Odds ratios and 95% confidence intervals for associations between fasting duration and abnormality of cardiovascular biomarkers in NHANES (2005–2016).
Quartiles of Fasting Duration

Biomarkers
CRP ≥ 3 mg/dL
Hb1Ac ≥ 6.5%
Insulin ≥ 10.57 uU/mL
Glucose ≥ 126 mg/dL
HDL ≤ 50 mg/dL
LDL ≥ 130 mg/dL
Cholesterol ≥ 210 mg/dL

Quartile 1

Quartile 2

Quartile 3

Quartile 4

Per 1 h

1.00 (Ref)
1.00 (Ref)
1.00 (Ref)
1.00 (Ref)
1.00 (Ref)
1.00 (Ref)
1.00 (Ref)

1.17 (1.00, 1.36)
1.06 (0.88, 1.26)
1.51 (1.31, 1.73)
1.00 (0.75, 1.34)
1.05 (0.95, 1.16)
1.03 (0.91, 1.17)
0.97 (0.89, 1.07)

1.20 (1.03, 1.40)
1.09 (0.93, 1.28)
1.62 (1.39, 1.89)
1.09 (0.87, 1.36)
1.03 (0.94, 1.12)
1.11 (0.97, 1.28)
1.07 (0.96, 1.19)

1.21 (1.05, 1.40)
1.01 (0.85, 1.21)
1.65 (1.37, 1.99)
1.13 (0.88, 1.44)
1.10 (1.00, 1.20)
1.10 (0.95, 1.28)
1.05 (0.92, 1.18)

1.01 (0.99, 1.04)
0.99 (0.97, 1.02)
1.07 (1.05, 1.10)
1.00 (0.97, 1.04)
1.01 (1.00, 1.03)
1.03 (1.00, 1.05)
1.01 (1.00, 1.03)

Abbreviations: CRP = C-reactive protein; HDL = high-density lipoproteins; LDL = low-density lipoproteins; HbA1c = glycosylated
hemoglobin; Ref = reference. Model adjusted for age (per 10 years), race, gender, marital status, alcohol use, body mass index, smoking
status, sleep duration, cholesterol medicine, days for dietary reports, energy intake, and the Dietary Inflammatory Index. Quartile ranges:
Quartile 1: <10.75, Quartile 2: 10.75–12.16, Quartile 3: 12.17–13.74, Quartile 4: ≥10.75.

In attempts to understand results for fasting duration in the opposite direction than
hypothesized, post hoc analyses examined last and first mealtimes. For last mealtimes,
every one-hour increase in fasting was associated with a 0.873 (SE = 0.306, p = 0.01) lower
value in LDL and a higher HbA1c % (β = 0.008, SE = 0.004, p = 0.05). Those in the last
quartile (i.e., latest times) for last mealtime had higher levels of HbA1c % and insulin but
lower values LDL and total cholesterol (all p < 0.05) compared to the first quartile. For the
first mealtime, every one-hour increase was associated with an increase in CRP (β = 0.044,
SE = 0.017, p = 0.0106), insulin (β = 0.429, SE = 0.105, p < 0.01), and glucose (β = 0.662,
SE = 0.185, p < 0.01), and a decrease in HDL (β = −0.377, SE = 0.073, p < 0.01). Similarly,
statistically significantly greater means in quartile 4 (latest first mealtime) compared to
quartile 1 were observed for CRP, HbA1c %, insulin, and glucose, and lower HDL (Table 4).
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Table 4. Associations (least square means and standard errors) between time of last meal and first meal and cardiometabolic
biomarkers in NHANES (2005–2016).
Last Mealtime
Biomarker
CRP, mg/dL
Hb1Ac, %
Insulin, uU/mL
Glucose, mg/dL
HDL, mg/dL
LDL, mg/dL
Cholesterol, mg/dL

Quartiles of Time of Last Meal
Quartile 1

Quartile 2

Quartile 3

Quartile 4

Per 1 h
β ± SE

Cont.
p-Value

2.84 (0.08)
5.83 (0.02)
12.5 (0.46)
110.9 (0.85)
53.9 (0.35)
108.2 (1.48)
188.5 (0.96)

2.86 (0.10)
5.85 (0.02)
13.3 (0.52) *
110.8 (0.81)
54.3 (0.33)
107.0 (1.45)
188.0 (0.86)

2.87 (0.08)
5.87 (0.02)
13.7 (0.36) *
112.2 (0.81)
53.9 (0.32)
107.2 (1.01)
188.2 (0.74)

2.89 (0.09)
5.87 (0.02) *
13.4 (0.39) *
112.1(0.88)
53.7 (0.31)
104.1 (1.12) *
186.4 (0.75) *

−0.002 (0.022)
0.009 (0.005)
0.040 (0.082)
0.371 (0.223)
−0.104 (0.070)
−0.873 (0.306)
−0.378 (0.224)

0.94
0.05
0.63
0.10
0.14
0.01
0.10

First Mealtime
Biomarker
CRP, mg/dL
Hb1Ac, %
Insulin, uU/mL
Glucose, mg/dL
HDL, mg/dL
LDL, mg/dL
Cholesterol, mg/dL

Quartiles of Time of First Meal
Quartile 1

Quartile 2

Quartile 3

Quartile 4

Per 1 h
β ± SE

Cont.
p-Value

2.72 (0.09)
5.84 (0.02)
11.9 (0.51)
109.7 (0.84)
54.7 (0.30)
106.3 (0.91)
187.0 (0.67)

2.86 (0.10)
5.82 (0.02)
12.7 (0.46) *
109.7 (0.82)
54.4 (0.38)
106.7 (1.12)
188.9 (0.82) *

2.95 (0.08) *
5.87 (0.02) *
13.2 (0.43) *
111.9 (0.71) *
53.1 (0.29) *
107.3 (1.26)
187.3 (0.87)

2.96 (0.09) *
5.90 (0.02) *
14.8 (0.35) *
114.5 (1.16) *
53.1 (0.34) *
104.6 (1.18)
185.9 (0.80)

0.044 (0.017)
0.007 (0.004)
0.429 (0.105)
0.662 (0.185)
−0.377 (0.073)
−0.361 (0.209)
−0.302 (0.154)

0.01
0.06
<0.01
<0.01
<0.01
0.09
0.05

Abbreviations: CRP = C-reactive protein; DII = Dietary Inflammation Index; HDL = high-density lipoproteins; LDL = low-density
lipoproteins; HbA1c = glycosylated hemoglobin. Model adjusted for age (per 10 years), race, gender, marital status, alcohol use, body mass
index, smoking status, sleep duration, cholesterol medicine, days for dietary reports, and the Dietary Inflammatory Index. The last meal
time was additionally adjusted for total energy intake between 3:00–8:00 p.m. and 8:00+ p.m. First meal intake was additionally adjusted
for total energy intake between 4:00–10:00 a.m. and 10:00 a.m.–3 p.m. First mealtime quartile ranges: Quartile 1: <7:23 a.m., Quartile 2:
7:23–8:30 a.m., Quartile 3: 8:30–9:45 a.m., Quartile 4: ≥9:46 a.m. Last mealtime quartile ranges: Quartile 1: <7:15PM, Quartile 2: 7:15–8:15
p.m., Quartile 3: 8:16–9:30 p.m., Quartile 4: ≥9:30 p.m. * Represents means that were statistically significantly (p < 0.05) different compared
to quartile 1.

To further explore the differences in results between fasting duration and first mealtime, results for first mealtime were stratified by fasting duration. Largely speaking, results
for first mealtime among the total population were observed in quartile 1 and quartile 4 of
fasting duration separately. For example, those with the latest first mealtime (i.e., quartile 4
of first mealtime) compared to the earliest first mealtime had statistically significant greater
insulin among those with shorter fasting durations (14.0 vs. 11.9 uU/mL, p = 0.06) and in
those with the longest fasting durations (14.7 vs. 10.4 uU/mL, p ≤ 0.01). Similar patterns of
results (i.e., healthier values in the earliest mealtime regardless of fasting duration quartile)
were observed for glucose. For HDL, a later first mealtime was associated with lower (i.e.,
worse) values compared to an earlier first mealtime, but only among those with shorter
fasting durations (Table 5).
A few sensitivity analyses were performed for the results related to fasting duration
in Table 2. First, we excluded those who were suspected of being shift workers, then those
with extreme fasting durations (i.e., ≤2 or ≥23 h), and those who had a dietary report on
the weekend (data not tabulated). With none of these did the interpretation of the findings
change compared to results presented in Table 2.
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Table 5. Least square means and standard errors of outcomes by quartiles 1 and 4 of first mealtime
and fasting duration in NHANES (2005–2016).
Quartiles of First
Mealtime
CRP, mg/dL
Quartile 1
Quartile 4
Hb1Ac, %
Quartile 1
Quartile 4
Insulin, uU/mL
Quartile 1
Quartile 4
Glucose, mg/dL
Quartile 1
Quartile 4
HDL, mg/dL
Quartile 1
Quartile 4
LDL, mg/dL
Quartile 1
Quartile 4
Cholesterol, mg/dL
Quartile 1
Quartile 4

Quartiles of Fasting Duration
Quartile 1

Quartile 4

2.60 (0.10)
2.65 (0.21)

3.43 (0.35)
3.08 (0.09)

5.86 (0.02)
5.87 (0.05)

5.80 (0.08)
5.89 (0.02)

11.9 (0.64)
14.0 (1.19)

10.4 (0.74)
14.7 (0.4) *

110.3 (1.11)
113.6 (2.86)

108.57 (2.6)
114.1 (1.41) *

54.9 (0.34)
52.3 (1.03) *

52.5 (1.21)
53.2 (0.04)

106.3 (1.10)
102.4 (3.65)

110.7 (4.50)
105.3 (1.26)

186.9 (0.78)
181.9 (2.25) *

188.8 (3.36)
186.0 (0.93)

Interaction
p-Value
0.10

0.04

0.72

0.92

0.19

0.66

0.48

Abbreviations: CRP = C-reactive protein; HDL = high-density lipoproteins; LDL = low-density lipoproteins;
SE = standard error; HbA1c = glycosylated hemoglobin. Models adjusted for age (per 10 years), race, gender,
marital status, alcohol use, body mass index, smoking status, sleep duration, cholesterol medicine, days for
dietary reports, energy intake, and the Dietary Inflammatory Index and total energy intake between 4 a.m.–10
a.m. and 10 a.m.–3 p.m. Interaction p-values represent the p-values for the multiplicative interaction between
first mealtime and fasting duration quartiles. * Represents means that were statistically significantly (p < 0.05)
different between fasting quartiles within quartile 1 or 4 of fasting duration.

4. Discussion
One concern with calorie restriction-based diet programs is weight regain [5,6]. Of
growing interest, fasting and other chrononutrition-focused approaches (e.g., consuming
a majority of calories early in the morning) have shown potential for improvements in
cardiometabolic endpoints, as well as sustainability [37]. However, most of this work
has been conducted in smaller scale intervention studies or pragmatic designs using
Ramadan [26].
Therefore, this study examined the associations between nighttime fasting duration,
first mealtime, and last mealtime with a range of cardiometabolic endpoints using representative data from NHANES. Two previous studies have examined meal timing-related
constructs within NHANES. Previously, Kant and colleagues investigated the timing of
breakfast, lunch, and dinner by sex and race in NHANES [49]. Marinac and colleagues
found that for every 10% increase in calories consumed after 5:00 p.m. was associated with
a 3% increase in CRP among women from a single two-year cycle of NHANES [50]. These
studies were either descriptive in nature or only focused on women from a single two-year
cycle of NHANES data.
Results of the current study related to fasting duration were mainly in the opposite
direction than hypothesized. Increased fasting duration was associated with increased
CRP and insulin, and decreased HDL. Additionally, positive point estimates were observed
for the association between increased fasting duration and both LDL and total cholesterol
although the estimates did not quite achieve statistical significance.
Studies using observational or pragmatic designs have shown associations between
fasting and inflammatory markers [31,32]. For example, Faris and colleagues noted statistically and clinically significant reductions in interleukin (IL)-6, IL-1β, and tumor necrosis
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factor (TNF)-α at the end of Ramadan compared to prior to Ramadan [51]. Even though
the current study did not use these inflammatory markers, such results conflict with the
current findings. Interestingly, intervention studies tend to be inconsistent with no clear
relationship between fasting and inflammatory markers [33,34]. The findings from the
current study highlight the need to consider clinical importance, as opposed to statistical
significance. Although longer fasting durations were statistically significantly associated
with increased CRP, the beta coefficient was only 0.03 for a 1-h difference in fasting duration.
Taken in context, a 10-h fasting difference between two individuals would equate to a
0.3 mg/L difference in CRP which is not biologically meaningful. Given this, results of the
current study related to CRP are somewhat corroborated by past intervention studies.
Much of the work examining associations between metabolic endpoints and IF protocols tend to show beneficial effects. For example, one study employed a 10-h TRF protocol
among participants with metabolic syndrome over 12 weeks and found fasting glucose
decreased by 21% and HOMA-IR by 30% [34]. Jamshed and colleagues conducted an RCT
where control participants consumed meals at 800, 1400, and 2000 h. The eTRF group
consumed meals at 800, 1100, and 1400 h. In the eTRF group, 24-h mean glucose levels
were reduced by 4 ± 1 mg/dL [52]. In the current study, every one-hour increase in fasting
duration was associated with an increase in insulin by about 0.29 µU/mL which is opposite
of what was expected.
As for cardiovascular markers, HDL was found to decrease with increased fasting
duration and total and LDL cholesterol increased. However, again, results are not very
clinically meaningful. This is consistent with previous research. A meta-analysis observed
that the weighted mean difference between TRF and control groups for total cholesterol
(2.43 mg/dL), HDL cholesterol (0.76 mg/dL), and LDL cholesterol (−0.44 mg/dL) were
not statistically or clinically significant [26].
Although most results for fasting duration were not of clinical significance, the fairly
consistent conclusion that results trended in a direction opposite of the hypothesis was
perplexing. To further investigate this phenomenon, the timing of the last meal of the day
and first meal of the day were analyzed. It was interesting to observe that later timing
of the last meal was associated with higher HbA1c % and insulin which is somewhat
supported by increased peripheral and hepatic insulin resistance observed towards the
evening hours [29,30]. At the same time, LDL and total cholesterol were lower with later
timing of the last meal. This is partially supported by work indicating that a greater meal
frequency, which is often associated with consumption later into the evening, is associated
with lower LDL and total cholesterol [53].
Every one-hour increase in the time of first meal was associated with higher CRP,
HbA1c %, insulin, and glucose and lower HDL cholesterol. Previously, every one-hour
increase in first meal consumption was associated with an increase in glycoprotein acetyl, a
pro-inflammatory marker [54]. The phenomenon of a later time of first meal consumption
may be analogous to breakfast skipping. Compared to always eating breakfast, those never
eating breakfast had an increased odds of having a CRP value above 3.0 mg/L of 1.27
(95%CI = 1.15–1.40) [55]. In a review including 105 peer-reviewed publications, it was
concluded that regular breakfast consumption, compared to regularly skipping, improved
carbohydrate metabolism and reduced T2DM risk [56]. Interestingly, when results were
stratified by fasting duration quartiles in the current study, there was no clear pattern in
CRP values other than longer fasting durations having larger CRP values.
An earlier breakfast is also a key feature of eTRF. As noted above, Jamshed and
colleagues observed reduced blood glucose with an eTRF protocol [52]. Another study
that was a cross-over design among men with pre-diabetes randomized men to a control
condition with meals at 700, 1300, and 1900 h and an intervention arm with meals at 700,
1000, and 1300 h. eTRF led to reduced fasting insulin by 3.4 ± 1.6 mU/L. Insulin levels
were also reduced at 60 and 90 min post-load [57]. Starting consumption earlier in the
day and ending earlier in the evening has been shown to have numerous cardiometabolic
effects. Human studies have shown decreased insulin secretion and peripheral and hepatic
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insulin resistance in the evening compared to the morning [29,30], and later evening
meals, compared to identical morning meals, result in hyperglycemic responses [58]. This
could ultimately lead to increased systemic inflammation given that chronically high
levels of glucose in the blood is a pro-inflammatory state, in and of itself [59]. When first
mealtime results were stratified by fasting duration for the metabolic markers, results
for first mealtime persisted across fasting duration quartiles. In other words, a later
first mealtime, compared to earlier, was associated with increased (i.e., worse) metabolic
parameters (i.e., insulin, glucose, and HbA1c %) regardless of fasting duration. Healthier
(i.e., higher) HDL was observed among those with earlier first mealtimes, compared to
later, but only among those with shorter fasting durations.
Strengths of this study include use of a large representative sample of the US population. Previous research by others has primarily relied on small highly controlled clinical
trials or pragmatic designs involving Ramadan [36,37]. Such studies may be underpowered
to test associations of interest or findings may not be generalizable to the general population. This is especially true of small clinical trials which often include relatively healthy
participants from more affluent backgrounds. Most participants provided two days of
24HR which were averaged together to estimate fasting durations. This helps to address
day-to-day variability in dietary reporting. NHANES uses rigorous biological sampling
procedures. Lastly, a range of covariates were available for inclusion in models to account
for a range of possible confounders.
However, this study was subject to a few limitations. One limitation may be the potential for residual confounding based on how the “nighttime fasting period” was defined.
The 24HR started at midnight and went to 11:59 p.m. The difficulty with characterization
of fasting durations given this diet collection protocol is that the sleep period is unknown
and consecutive days of 24HR may not have been available. Hence, it was not possible
to truly estimate the fasting period from one night to the next morning. Instead, last and
first mealtimes had to be estimated which was difficult in situations where meals were
consumed in the very early morning hours. However, a series of sensitivity analyses
were conducted including removing those suspected of being shift workers, those with
extreme fasting durations, and those with weekend dietary reports to try to account for
potential biases related to how fasting was calculated. As with most cross-sectional studies,
reverse causality is a concern. However, it is hard to conceive how abnormal inflammatory or metabolic markers could cause someone to change their fasting durations in the
general population.
5. Conclusions
This study found that longer fasting durations were associated with higher CRP,
insulin, and lower HDL cholesterol. These findings are in the opposite direction of what
most of the literature has shown. However, upon further investigation, it was found that a
later time of first meal consumption was associated with higher CRP, HbA1c %, insulin,
glucose, and total and LDL cholesterol, and lower HDL cholesterol. Some of these findings
resemble findings related to breakfast skipping. It is conceivable that through unhealthy
eating practices (e.g., skipping breakfast, only eating one meal a day), that individuals
artifactually create a longer fasting period which, in turn, is associated with abnormal
biomarker levels. It would be interesting to conduct future studies among the general
public using more rigorous meal timing data collection procedures to see if a similar
phenomenon persists. Regardless, findings from this study tend to support evidence
indicating that starting food consumption earlier in the day (e.g., eTRF) has beneficial
cardiometabolic effects.
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